Loading…

Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells

Recent clinical and experimental evidences strongly acclaim Yes-associated protein (Yap), a key oncogenic driver in liver carcinogenesis, as a therapeutic target. Of the known multiple schemes to inhibit Yap activity, activation of Mammalian Sterile 20-like Kinase 1 (Mst1), an upstream regulator of...

Full description

Saved in:
Bibliographic Details
Published in:Experimental cell research 2017-06, Vol.355 (2), p.124-141
Main Authors: Perumal, NaveenKumar, Perumal, MadanKumar, Kannan, Anbarasu, Subramani, Kumar, Halagowder, Devaraj, Sivasithamparam, NiranjaliDevaraj
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c387t-ab0a1abb8e9d416b5ce81bc9af0f56283f81657c0cd4cf9e902ae127f2a5197b3
cites cdi_FETCH-LOGICAL-c387t-ab0a1abb8e9d416b5ce81bc9af0f56283f81657c0cd4cf9e902ae127f2a5197b3
container_end_page 141
container_issue 2
container_start_page 124
container_title Experimental cell research
container_volume 355
creator Perumal, NaveenKumar
Perumal, MadanKumar
Kannan, Anbarasu
Subramani, Kumar
Halagowder, Devaraj
Sivasithamparam, NiranjaliDevaraj
description Recent clinical and experimental evidences strongly acclaim Yes-associated protein (Yap), a key oncogenic driver in liver carcinogenesis, as a therapeutic target. Of the known multiple schemes to inhibit Yap activity, activation of Mammalian Sterile 20-like Kinase 1 (Mst1), an upstream regulator of Yap, appears to be a promising one. In this study, we hypothesize that morin, a bioflavonoid, mediates its anti-cancer effect through the activation of Mst1/hippo signaling in liver cancer cells. To test this hypothesis, both full length Mst1 (F-Mst1) and kinase active N-terminal Mst1 (N-Mst1)-overexpressed HepG2 cells were used. Exposure of F-Mst1 overexpressed HepG2 cells to morin activated Mst1 by caspase-3 cleavage and thereby inhibited Yap nuclear translocation and fostered apoptosis. Morin suppressed NF-κB p65 and Wnt/β-catenin signaling through Mst1 activation via cleavage and phosphorylation, leading to cell death. Annexin-V/PI staining further confirmed the induction of apoptosis in morin treated F-Mst1 overexpressed cells. The present study shows that morin targets cell survival molecules such as NF-κB p65 and β-catenin through activation of hippo signaling. Therefore, morin could be considered as a potential anti-cancer agent against liver cancer. [Display omitted] •Morin induced cytotoxicity in cultured HepG2 cells.•Morin activated hippo pathway via Mst1 activation in transfected HepG2 cells.•Morin suppressed Wnt/β-catenin signaling and induced G0/G1 cell cycle arrest.•Morin inhibited NF-κB signaling through Mst1 activation in transfected HepG2 cells.•Morin potentiates apoptosis through Mst1-JNK-caspase mediated mechanism in HepG2 cells.
doi_str_mv 10.1016/j.yexcr.2017.03.062
format article
fullrecord <record><control><sourceid>pubmed_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_22649860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001448271730191X</els_id><sourcerecordid>28366538</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-ab0a1abb8e9d416b5ce81bc9af0f56283f81657c0cd4cf9e902ae127f2a5197b3</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EotPCEyAhS6yTXjuJkyxYQNU_qaWbIsTKcpybGY8ydmR7qvZVeAyWfYg-U50GWLK6kvUd3_vpEPKBQc6AieNt_oD32uccWJ1DkYPgr8iKQQsZLzl_TVYArMzKhtcH5DCELQA0DRNvyQFvCiGqolmRX9fOG0vNbsIeA_2pJmr3ekTlafTKhtFpFY2zVNmeDi5E9IGqyU3RBRNo3Hi3X29o2E-TxxDmpBvoDxuPn35nCUVrFvbbWfb0-JUGs7ZqNHZN0_t1iIy6O_R4_0JjTy9wOudU4ziGd-TNoMaA7__MI_L97PT25CK7ujm_PPlylemiqWOmOlBMdV2DbV8y0VUaG9bpVg0wVCI1HVLnqtag-1IPLbbAFTJeD1xVrK274oh8Wv5N7YwM2kTUG-2sRR0l56JsGwEpVSwp7V0IHgc5ebNT_kEykLMPuZUvPuTsQ0Ihk49EfVyoad_tsP_H_BWQAp-XAKaGdwb9fABajb3x8_7emf8ueAYj1qHz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells</title><source>Elsevier</source><creator>Perumal, NaveenKumar ; Perumal, MadanKumar ; Kannan, Anbarasu ; Subramani, Kumar ; Halagowder, Devaraj ; Sivasithamparam, NiranjaliDevaraj</creator><creatorcontrib>Perumal, NaveenKumar ; Perumal, MadanKumar ; Kannan, Anbarasu ; Subramani, Kumar ; Halagowder, Devaraj ; Sivasithamparam, NiranjaliDevaraj</creatorcontrib><description>Recent clinical and experimental evidences strongly acclaim Yes-associated protein (Yap), a key oncogenic driver in liver carcinogenesis, as a therapeutic target. Of the known multiple schemes to inhibit Yap activity, activation of Mammalian Sterile 20-like Kinase 1 (Mst1), an upstream regulator of Yap, appears to be a promising one. In this study, we hypothesize that morin, a bioflavonoid, mediates its anti-cancer effect through the activation of Mst1/hippo signaling in liver cancer cells. To test this hypothesis, both full length Mst1 (F-Mst1) and kinase active N-terminal Mst1 (N-Mst1)-overexpressed HepG2 cells were used. Exposure of F-Mst1 overexpressed HepG2 cells to morin activated Mst1 by caspase-3 cleavage and thereby inhibited Yap nuclear translocation and fostered apoptosis. Morin suppressed NF-κB p65 and Wnt/β-catenin signaling through Mst1 activation via cleavage and phosphorylation, leading to cell death. Annexin-V/PI staining further confirmed the induction of apoptosis in morin treated F-Mst1 overexpressed cells. The present study shows that morin targets cell survival molecules such as NF-κB p65 and β-catenin through activation of hippo signaling. Therefore, morin could be considered as a potential anti-cancer agent against liver cancer. [Display omitted] •Morin induced cytotoxicity in cultured HepG2 cells.•Morin activated hippo pathway via Mst1 activation in transfected HepG2 cells.•Morin suppressed Wnt/β-catenin signaling and induced G0/G1 cell cycle arrest.•Morin inhibited NF-κB signaling through Mst1 activation in transfected HepG2 cells.•Morin potentiates apoptosis through Mst1-JNK-caspase mediated mechanism in HepG2 cells.</description><identifier>ISSN: 0014-4827</identifier><identifier>EISSN: 1090-2422</identifier><identifier>DOI: 10.1016/j.yexcr.2017.03.062</identifier><identifier>PMID: 28366538</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; Active Transport, Cell Nucleus - drug effects ; Adaptor Proteins, Signal Transducing - metabolism ; APOPTOSIS ; Apoptosis - drug effects ; beta Catenin - metabolism ; BIOFLAVONOIDS ; CARCINOGENESIS ; CELL CYCLE ; Cell Nucleus - metabolism ; Dose-Response Relationship, Drug ; Flavonoids - pharmacology ; Gene Expression Profiling ; Hep G2 Cells ; Hippo signaling ; Humans ; INHIBITION ; LIVER ; MOLECULES ; MORIN ; Mst1 ; NEOPLASMS ; NF-kappa B - metabolism ; NF-κB signaling ; Phosphoproteins - metabolism ; PHOSPHORYLATION ; PHOSPHOTRANSFERASES ; Protein-Serine-Threonine Kinases - genetics ; Protein-Serine-Threonine Kinases - metabolism ; Structure-Activity Relationship ; TOXICITY ; Transcription Factors ; TRANSLOCATION ; Wnt Proteins - metabolism ; Wnt Signaling Pathway - drug effects ; β-catenin</subject><ispartof>Experimental cell research, 2017-06, Vol.355 (2), p.124-141</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-ab0a1abb8e9d416b5ce81bc9af0f56283f81657c0cd4cf9e902ae127f2a5197b3</citedby><cites>FETCH-LOGICAL-c387t-ab0a1abb8e9d416b5ce81bc9af0f56283f81657c0cd4cf9e902ae127f2a5197b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28366538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/22649860$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Perumal, NaveenKumar</creatorcontrib><creatorcontrib>Perumal, MadanKumar</creatorcontrib><creatorcontrib>Kannan, Anbarasu</creatorcontrib><creatorcontrib>Subramani, Kumar</creatorcontrib><creatorcontrib>Halagowder, Devaraj</creatorcontrib><creatorcontrib>Sivasithamparam, NiranjaliDevaraj</creatorcontrib><title>Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>Recent clinical and experimental evidences strongly acclaim Yes-associated protein (Yap), a key oncogenic driver in liver carcinogenesis, as a therapeutic target. Of the known multiple schemes to inhibit Yap activity, activation of Mammalian Sterile 20-like Kinase 1 (Mst1), an upstream regulator of Yap, appears to be a promising one. In this study, we hypothesize that morin, a bioflavonoid, mediates its anti-cancer effect through the activation of Mst1/hippo signaling in liver cancer cells. To test this hypothesis, both full length Mst1 (F-Mst1) and kinase active N-terminal Mst1 (N-Mst1)-overexpressed HepG2 cells were used. Exposure of F-Mst1 overexpressed HepG2 cells to morin activated Mst1 by caspase-3 cleavage and thereby inhibited Yap nuclear translocation and fostered apoptosis. Morin suppressed NF-κB p65 and Wnt/β-catenin signaling through Mst1 activation via cleavage and phosphorylation, leading to cell death. Annexin-V/PI staining further confirmed the induction of apoptosis in morin treated F-Mst1 overexpressed cells. The present study shows that morin targets cell survival molecules such as NF-κB p65 and β-catenin through activation of hippo signaling. Therefore, morin could be considered as a potential anti-cancer agent against liver cancer. [Display omitted] •Morin induced cytotoxicity in cultured HepG2 cells.•Morin activated hippo pathway via Mst1 activation in transfected HepG2 cells.•Morin suppressed Wnt/β-catenin signaling and induced G0/G1 cell cycle arrest.•Morin inhibited NF-κB signaling through Mst1 activation in transfected HepG2 cells.•Morin potentiates apoptosis through Mst1-JNK-caspase mediated mechanism in HepG2 cells.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Active Transport, Cell Nucleus - drug effects</subject><subject>Adaptor Proteins, Signal Transducing - metabolism</subject><subject>APOPTOSIS</subject><subject>Apoptosis - drug effects</subject><subject>beta Catenin - metabolism</subject><subject>BIOFLAVONOIDS</subject><subject>CARCINOGENESIS</subject><subject>CELL CYCLE</subject><subject>Cell Nucleus - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Flavonoids - pharmacology</subject><subject>Gene Expression Profiling</subject><subject>Hep G2 Cells</subject><subject>Hippo signaling</subject><subject>Humans</subject><subject>INHIBITION</subject><subject>LIVER</subject><subject>MOLECULES</subject><subject>MORIN</subject><subject>Mst1</subject><subject>NEOPLASMS</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB signaling</subject><subject>Phosphoproteins - metabolism</subject><subject>PHOSPHORYLATION</subject><subject>PHOSPHOTRANSFERASES</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>TOXICITY</subject><subject>Transcription Factors</subject><subject>TRANSLOCATION</subject><subject>Wnt Proteins - metabolism</subject><subject>Wnt Signaling Pathway - drug effects</subject><subject>β-catenin</subject><issn>0014-4827</issn><issn>1090-2422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAURi0EotPCEyAhS6yTXjuJkyxYQNU_qaWbIsTKcpybGY8ydmR7qvZVeAyWfYg-U50GWLK6kvUd3_vpEPKBQc6AieNt_oD32uccWJ1DkYPgr8iKQQsZLzl_TVYArMzKhtcH5DCELQA0DRNvyQFvCiGqolmRX9fOG0vNbsIeA_2pJmr3ekTlafTKhtFpFY2zVNmeDi5E9IGqyU3RBRNo3Hi3X29o2E-TxxDmpBvoDxuPn35nCUVrFvbbWfb0-JUGs7ZqNHZN0_t1iIy6O_R4_0JjTy9wOudU4ziGd-TNoMaA7__MI_L97PT25CK7ujm_PPlylemiqWOmOlBMdV2DbV8y0VUaG9bpVg0wVCI1HVLnqtag-1IPLbbAFTJeD1xVrK274oh8Wv5N7YwM2kTUG-2sRR0l56JsGwEpVSwp7V0IHgc5ebNT_kEykLMPuZUvPuTsQ0Ihk49EfVyoad_tsP_H_BWQAp-XAKaGdwb9fABajb3x8_7emf8ueAYj1qHz</recordid><startdate>20170615</startdate><enddate>20170615</enddate><creator>Perumal, NaveenKumar</creator><creator>Perumal, MadanKumar</creator><creator>Kannan, Anbarasu</creator><creator>Subramani, Kumar</creator><creator>Halagowder, Devaraj</creator><creator>Sivasithamparam, NiranjaliDevaraj</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>OTOTI</scope></search><sort><creationdate>20170615</creationdate><title>Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells</title><author>Perumal, NaveenKumar ; Perumal, MadanKumar ; Kannan, Anbarasu ; Subramani, Kumar ; Halagowder, Devaraj ; Sivasithamparam, NiranjaliDevaraj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-ab0a1abb8e9d416b5ce81bc9af0f56283f81657c0cd4cf9e902ae127f2a5197b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Active Transport, Cell Nucleus - drug effects</topic><topic>Adaptor Proteins, Signal Transducing - metabolism</topic><topic>APOPTOSIS</topic><topic>Apoptosis - drug effects</topic><topic>beta Catenin - metabolism</topic><topic>BIOFLAVONOIDS</topic><topic>CARCINOGENESIS</topic><topic>CELL CYCLE</topic><topic>Cell Nucleus - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Flavonoids - pharmacology</topic><topic>Gene Expression Profiling</topic><topic>Hep G2 Cells</topic><topic>Hippo signaling</topic><topic>Humans</topic><topic>INHIBITION</topic><topic>LIVER</topic><topic>MOLECULES</topic><topic>MORIN</topic><topic>Mst1</topic><topic>NEOPLASMS</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB signaling</topic><topic>Phosphoproteins - metabolism</topic><topic>PHOSPHORYLATION</topic><topic>PHOSPHOTRANSFERASES</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>TOXICITY</topic><topic>Transcription Factors</topic><topic>TRANSLOCATION</topic><topic>Wnt Proteins - metabolism</topic><topic>Wnt Signaling Pathway - drug effects</topic><topic>β-catenin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perumal, NaveenKumar</creatorcontrib><creatorcontrib>Perumal, MadanKumar</creatorcontrib><creatorcontrib>Kannan, Anbarasu</creatorcontrib><creatorcontrib>Subramani, Kumar</creatorcontrib><creatorcontrib>Halagowder, Devaraj</creatorcontrib><creatorcontrib>Sivasithamparam, NiranjaliDevaraj</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>OSTI.GOV</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perumal, NaveenKumar</au><au>Perumal, MadanKumar</au><au>Kannan, Anbarasu</au><au>Subramani, Kumar</au><au>Halagowder, Devaraj</au><au>Sivasithamparam, NiranjaliDevaraj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>2017-06-15</date><risdate>2017</risdate><volume>355</volume><issue>2</issue><spage>124</spage><epage>141</epage><pages>124-141</pages><issn>0014-4827</issn><eissn>1090-2422</eissn><abstract>Recent clinical and experimental evidences strongly acclaim Yes-associated protein (Yap), a key oncogenic driver in liver carcinogenesis, as a therapeutic target. Of the known multiple schemes to inhibit Yap activity, activation of Mammalian Sterile 20-like Kinase 1 (Mst1), an upstream regulator of Yap, appears to be a promising one. In this study, we hypothesize that morin, a bioflavonoid, mediates its anti-cancer effect through the activation of Mst1/hippo signaling in liver cancer cells. To test this hypothesis, both full length Mst1 (F-Mst1) and kinase active N-terminal Mst1 (N-Mst1)-overexpressed HepG2 cells were used. Exposure of F-Mst1 overexpressed HepG2 cells to morin activated Mst1 by caspase-3 cleavage and thereby inhibited Yap nuclear translocation and fostered apoptosis. Morin suppressed NF-κB p65 and Wnt/β-catenin signaling through Mst1 activation via cleavage and phosphorylation, leading to cell death. Annexin-V/PI staining further confirmed the induction of apoptosis in morin treated F-Mst1 overexpressed cells. The present study shows that morin targets cell survival molecules such as NF-κB p65 and β-catenin through activation of hippo signaling. Therefore, morin could be considered as a potential anti-cancer agent against liver cancer. [Display omitted] •Morin induced cytotoxicity in cultured HepG2 cells.•Morin activated hippo pathway via Mst1 activation in transfected HepG2 cells.•Morin suppressed Wnt/β-catenin signaling and induced G0/G1 cell cycle arrest.•Morin inhibited NF-κB signaling through Mst1 activation in transfected HepG2 cells.•Morin potentiates apoptosis through Mst1-JNK-caspase mediated mechanism in HepG2 cells.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28366538</pmid><doi>10.1016/j.yexcr.2017.03.062</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4827
ispartof Experimental cell research, 2017-06, Vol.355 (2), p.124-141
issn 0014-4827
1090-2422
language eng
recordid cdi_osti_scitechconnect_22649860
source Elsevier
subjects 60 APPLIED LIFE SCIENCES
Active Transport, Cell Nucleus - drug effects
Adaptor Proteins, Signal Transducing - metabolism
APOPTOSIS
Apoptosis - drug effects
beta Catenin - metabolism
BIOFLAVONOIDS
CARCINOGENESIS
CELL CYCLE
Cell Nucleus - metabolism
Dose-Response Relationship, Drug
Flavonoids - pharmacology
Gene Expression Profiling
Hep G2 Cells
Hippo signaling
Humans
INHIBITION
LIVER
MOLECULES
MORIN
Mst1
NEOPLASMS
NF-kappa B - metabolism
NF-κB signaling
Phosphoproteins - metabolism
PHOSPHORYLATION
PHOSPHOTRANSFERASES
Protein-Serine-Threonine Kinases - genetics
Protein-Serine-Threonine Kinases - metabolism
Structure-Activity Relationship
TOXICITY
Transcription Factors
TRANSLOCATION
Wnt Proteins - metabolism
Wnt Signaling Pathway - drug effects
β-catenin
title Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A56%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Morin%20impedes%20Yap%20nuclear%20translocation%20and%20fosters%20apoptosis%20through%20suppression%20of%20Wnt/%CE%B2-catenin%20and%20NF-%CE%BAB%20signaling%20in%20Mst1%20overexpressed%20HepG2%20cells&rft.jtitle=Experimental%20cell%20research&rft.au=Perumal,%20NaveenKumar&rft.date=2017-06-15&rft.volume=355&rft.issue=2&rft.spage=124&rft.epage=141&rft.pages=124-141&rft.issn=0014-4827&rft.eissn=1090-2422&rft_id=info:doi/10.1016/j.yexcr.2017.03.062&rft_dat=%3Cpubmed_osti_%3E28366538%3C/pubmed_osti_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c387t-ab0a1abb8e9d416b5ce81bc9af0f56283f81657c0cd4cf9e902ae127f2a5197b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/28366538&rfr_iscdi=true